- Home
- OABI vs ETON Comparison
OABI vs ETON Comparison
Compare OABI & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- ETON
- Stock Information
- Founded
- OABI 2012
- ETON 2017
- Country
- OABI United States
- ETON United States
- Employees
- OABI N/A
- ETON N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- OABI Health Care
- ETON Health Care
- Exchange
- OABI Nasdaq
- ETON Nasdaq
- Market Cap
- OABI 389.7M
- ETON 329.8M
- IPO Year
- OABI N/A
- ETON 2018
- Fundamental
- Price
- OABI $3.65
- ETON $14.51
- Analyst Decision
- OABI Strong Buy
- ETON Strong Buy
- Analyst Count
- OABI 4
- ETON 3
- Target Price
- OABI $9.00
- ETON $24.00
- AVG Volume (30 Days)
- OABI 569.4K
- ETON 330.6K
- Earning Date
- OABI 03-19-2025
- ETON 03-13-2025
- Dividend Yield
- OABI N/A
- ETON N/A
- EPS Growth
- OABI N/A
- ETON N/A
- EPS
- OABI N/A
- ETON N/A
- Revenue
- OABI $20,409,000.00
- ETON $34,677,000.00
- Revenue This Year
- OABI N/A
- ETON $22.19
- Revenue Next Year
- OABI $78.61
- ETON $110.87
- P/E Ratio
- OABI N/A
- ETON N/A
- Revenue Growth
- OABI N/A
- ETON 5.64
- 52 Week Low
- OABI $3.10
- ETON $3.03
- 52 Week High
- OABI $6.55
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- OABI 53.96
- ETON 41.72
- Support Level
- OABI $3.61
- ETON $14.18
- Resistance Level
- OABI $4.02
- ETON $17.13
- Average True Range (ATR)
- OABI 0.18
- ETON 1.03
- MACD
- OABI 0.04
- ETON -0.50
- Stochastic Oscillator
- OABI 58.89
- ETON 7.80
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.